View Older Stories View More Recent Stories
-
Simon Property Group (SPG), Taubman Centers (TCO) Agree to Modified Deal at $43/Share, 18% Discount to Original Deal
-
Simon And Taubman Modify Merger Price To $43.00 Per Share In Cash
-
Form 13F-NT LAZARD ASSET MANAGEMENT For: Sep 30
-
Form 13F-HR LAZARD ASSET MANAGEMENT For: Sep 30
-
Urovant Sciences (UROV) Enters Into Definitive Agreement for Sumitovant Biopharma to Acquire All Outstanding Shares
-
Urovant Sciences Enters Into Definitive Agreement for Sumitovant Biopharma to Acquire All Outstanding Shares
-
Sumitovant Biopharma and Urovant Sciences Announce Sumitovant's Acquisition of Remaining Stake in Urovant
-
Form 40-17G LAZARD FUNDS INC
-
Minerals Technologies Announcement Regarding Elementis plc (“Elementis”)
-
G4S plc: Offer for G4S plc - North American Competition Clearances
-
Fiat Chrysler and Engie EPS to set up e-mobility joint venture
-
Lazard (LAZ) Reports October 2020 AUM
-
Lazard Reports October 2020 Assets Under Management
-
Three Keys Advises on the Sale of Global Knowledge
-
JCPenney Receives Court Approval for Asset Purchase Agreement with Brookfield, Simon and First Lien Lenders
-
Form 497 LAZARD FUNDS INC
-
Form 497 LAZARD RETIREMENT SERIES
-
Parataxis Capital Taps Investors from Hollywood to Wall Street for Equity Financing Round
-
MIC Reports Third Quarter 2020 Financial And Operational Results, Announces Agreement To Sell IMTT
-
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
-
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
-
Extension of GardaWorld Cash Offer
-
Analysis: Dealmakers see divided U.S. government favoring mergers and acquisitions
-
ImmunoGen Reports Recent Progress and Third Quarter 2020 Financial Results
-
FTS International Announces Successful Confirmation of Plan of Reorganization
-
Statement regarding Conditional Indicative Offer from Allied Universal
-
Form 10-Q Lazard Group LLC For: Sep 30
-
Form 10-Q Lazard Ltd For: Sep 30
-
Endurance Int'l (EIGI) to be Acquired by Clearlake Capital Group L.P. for $9.50 per Share
-
Endurance International Group Announces Agreement to be Acquired by Clearlake Capital Group L.P. for $9.50 per Share
-
Sam Whittaker Re-joins Lazard Financial Advisory as a Managing Director
-
Lazard snaps up PJT restructuring banker as COVID second wave hits
-
Stonepeak Announces Agreement to Acquire Astound Broadband from TPG for $8.1 Billion
-
X-37, LLC Appoints David Gluckman, M.D., to Board of Directors
-
Lazard Ltd. (LAZ) Tops Q3 EPS by 20c, Revenues Beat
-
Form 8-K Lazard Ltd For: Oct 29
-
Lazard Ltd Reports Third-quarter and Nine-month 2020 Results
-
G4S plc: G4S Shareholders Advised to Reject GardaWorld Inadequate Offer
-
G4S plc: G4S Shareholders Advised to Reject GardaWorld Inadequate Offer
-
JCPenney Signs Asset Purchase Agreement with Brookfield, Simon and First Lien Lenders, Charting Course for the Future
-
Lazard Ltd. (LAZ) Declares $0.47 Quarterly Dividend; 5.6% Yield
-
Lazard Declares Quarterly Dividend of $0.47 Per Share
-
Wedbush Securities Expands Investment Banking Group
-
Monte Rosa Therapeutics Strengthens Executive Leadership Team with New Appointments
-
DTE Energy (DTE) to spin-off Midstream business
-
DTE Energy announces intent to spin-off Midstream business
-
Ryan Hutchinson and Stefan Wimmer Join Lazard Asset Management
-
Abcam Announces Closing of Offering
-
Abcam Announces Closing of Offering
-
Aviation Week Network Announces A&D Mergers & Acquisitions Conference to Discuss Aerospace & Defense Deal-Making in 2020 and Beyond


